VERACYTE INC (VCYT) Fundamental Analysis & Valuation
NASDAQ:VCYT • US92337F1075
Current stock price
34.33 USD
+1.18 (+3.56%)
At close:
34.27 USD
-0.06 (-0.17%)
After Hours:
This VCYT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. VCYT Profitability Analysis
1.1 Basic Checks
- VCYT had positive earnings in the past year.
- VCYT had a positive operating cash flow in the past year.
- In multiple years VCYT reported negative net income over the last 5 years.
- Of the past 5 years VCYT 4 years had a positive operating cash flow.
1.2 Ratios
- VCYT has a better Return On Assets (4.72%) than 90.89% of its industry peers.
- VCYT has a better Return On Equity (5.07%) than 90.89% of its industry peers.
- The Return On Invested Capital of VCYT (4.59%) is better than 90.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.72% | ||
| ROE | 5.07% | ||
| ROIC | 4.59% |
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of VCYT (12.83%) is better than 91.67% of its industry peers.
- VCYT has a better Operating Margin (15.14%) than 91.86% of its industry peers.
- VCYT's Gross Margin of 70.10% is fine compared to the rest of the industry. VCYT outperforms 79.46% of its industry peers.
- In the last couple of years the Gross Margin of VCYT has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.14% | ||
| PM (TTM) | 12.83% | ||
| GM | 70.1% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
2. VCYT Health Analysis
2.1 Basic Checks
- VCYT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, VCYT has more shares outstanding
- VCYT has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- VCYT has an Altman-Z score of 17.51. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
- VCYT has a better Altman-Z score (17.51) than 86.24% of its industry peers.
- VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 17.51 |
ROIC/WACC0.48
WACC9.55%
2.3 Liquidity
- VCYT has a Current Ratio of 8.15. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- VCYT has a better Current ratio (8.15) than 72.48% of its industry peers.
- VCYT has a Quick Ratio of 7.81. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- VCYT has a better Quick ratio (7.81) than 70.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.15 | ||
| Quick Ratio | 7.81 |
3. VCYT Growth Analysis
3.1 Past
- VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 176.67%, which is quite impressive.
- Looking at the last year, VCYT shows a quite strong growth in Revenue. The Revenue has grown by 16.01% in the last year.
- Measured over the past years, VCYT shows a very strong growth in Revenue. The Revenue has been growing by 34.50% on average per year.
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%
3.2 Future
- The Earnings Per Share is expected to grow by 21.22% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 10.69% on average over the next years. This is quite good.
EPS Next Y27.72%
EPS Next 2Y22.38%
EPS Next 3Y19.54%
EPS Next 5Y21.22%
Revenue Next Year13.07%
Revenue Next 2Y12.71%
Revenue Next 3Y11.92%
Revenue Next 5Y10.69%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. VCYT Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 41.36, the valuation of VCYT can be described as expensive.
- 90.89% of the companies in the same industry are more expensive than VCYT, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of VCYT to the average of the S&P500 Index (27.42), we can say VCYT is valued expensively.
- With a Price/Forward Earnings ratio of 32.39, VCYT can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 92.44% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 22.29, VCYT is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.36 | ||
| Fwd PE | 32.39 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, VCYT is valued cheaply inside the industry as 92.44% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 95.16% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.54 | ||
| EV/EBITDA | 22.72 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- VCYT has a very decent profitability rating, which may justify a higher PE ratio.
- VCYT's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.49
PEG (5Y)N/A
EPS Next 2Y22.38%
EPS Next 3Y19.54%
5. VCYT Dividend Analysis
5.1 Amount
- No dividends for VCYT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VCYT Fundamentals: All Metrics, Ratios and Statistics
34.33
+1.18 (+3.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25 2026-02-25/amc
Earnings (Next)05-05 2026-05-05/amc
Inst Owners110.9%
Inst Owner Change-0.01%
Ins Owners0.91%
Ins Owner Change7.49%
Market Cap2.73B
Revenue(TTM)517.14M
Net Income(TTM)66.35M
Analysts82.11
Price Target49.52 (44.25%)
Short Float %8.05%
Short Ratio6.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.79%
Min EPS beat(2)79.03%
Max EPS beat(2)132.56%
EPS beat(4)3
Avg EPS beat(4)43.36%
Min EPS beat(4)-110.32%
Max EPS beat(4)132.56%
EPS beat(8)6
Avg EPS beat(8)164.25%
EPS beat(12)8
Avg EPS beat(12)72.71%
EPS beat(16)12
Avg EPS beat(16)65.75%
Revenue beat(2)2
Avg Revenue beat(2)3.25%
Min Revenue beat(2)3.19%
Max Revenue beat(2)3.31%
Revenue beat(4)4
Avg Revenue beat(4)3.32%
Min Revenue beat(4)1.01%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)3.84%
Revenue beat(12)11
Avg Revenue beat(12)4.44%
Revenue beat(16)15
Avg Revenue beat(16)5.09%
PT rev (1m)-1.29%
PT rev (3m)-0.37%
EPS NQ rev (1m)41.85%
EPS NQ rev (3m)10.09%
EPS NY rev (1m)-8.37%
EPS NY rev (3m)-0.93%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)1.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.36 | ||
| Fwd PE | 32.39 | ||
| P/S | 5.27 | ||
| P/FCF | 21.54 | ||
| P/OCF | 20.01 | ||
| P/B | 2.08 | ||
| P/tB | 6.02 | ||
| EV/EBITDA | 22.72 |
EPS(TTM)0.83
EY2.42%
EPS(NY)1.06
Fwd EY3.09%
FCF(TTM)1.59
FCFY4.64%
OCF(TTM)1.72
OCFY5%
SpS6.51
BVpS16.48
TBVpS5.7
PEG (NY)1.49
PEG (5Y)N/A
Graham Number17.5437 (-48.9%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.72% | ||
| ROE | 5.07% | ||
| ROCE | 5.82% | ||
| ROIC | 4.59% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 80.43% | ||
| OM | 15.14% | ||
| PM (TTM) | 12.83% | ||
| GM | 70.1% | ||
| FCFM | 24.49% |
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
F-Score8
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.19% | ||
| Cap/Sales | 1.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 136.72% | ||
| Profit Quality | 190.84% | ||
| Current Ratio | 8.15 | ||
| Quick Ratio | 7.81 | ||
| Altman-Z | 17.51 |
F-Score8
WACC9.55%
ROIC/WACC0.48
Cap/Depr(3y)43.31%
Cap/Depr(5y)38.08%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
EPS Next Y27.72%
EPS Next 2Y22.38%
EPS Next 3Y19.54%
EPS Next 5Y21.22%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%
Revenue Next Year13.07%
Revenue Next 2Y12.71%
Revenue Next 3Y11.92%
Revenue Next 5Y10.69%
EBIT growth 1Y301.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year206.27%
EBIT Next 3Y58.21%
EBIT Next 5Y37.84%
FCF growth 1Y98.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.51%
OCF growth 3Y162.45%
OCF growth 5YN/A
VERACYTE INC / VCYT Fundamental Analysis FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 7 / 10 to VCYT.
What is the valuation status of VERACYTE INC (VCYT) stock?
ChartMill assigns a valuation rating of 5 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
Can you provide the profitability details for VERACYTE INC?
VERACYTE INC (VCYT) has a profitability rating of 7 / 10.
Can you provide the financial health for VCYT stock?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.